Cargando…

Antibody-based immunotherapies for Parkinsonian syndromes

Detalles Bibliográficos
Autores principales:	Tönges, Lars, Zella, Maria Angela Samis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676879/ https://www.ncbi.nlm.nih.gov/pubmed/31290443 http://dx.doi.org/10.4103/1673-5374.259613

Ejemplares similares

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort
por: Chen, Qiang, et al.
Publicado: (2023)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Short-chain fatty acids in the context of Parkinson’s disease
por: Metzdorf, Judith, et al.
Publicado: (2021)

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
por: Rohmann, Rachel, et al.
Publicado: (2021)

Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2023)

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology
por: Richter, Daniel, et al.
Publicado: (2019)

Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine
por: Bono, Federica, et al.
Publicado: (2021)

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
por: Mahlknecht, Philipp, et al.
Publicado: (2012)

Governing Collaborative Healthcare Improvement: Lessons From an Atlantic Canadian Case
por: Rossiter, Meghan, et al.
Publicado: (2017)

Could Spinal Canal Compression be a Cause of Polyneuropathy?
por: Bostelmann, Richard, et al.
Publicado: (2016)

Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies
por: Endres, Dominique, et al.
Publicado: (2020)

Epidemiology of atypical parkinsonian syndromes
por: Lo, Raymond Y.
Publicado: (2021)

Successful therapy with rituximab in three patients with probable neurosarcoidosis
por: Zella, Samis, et al.
Publicado: (2018)

NK cell-based immunotherapy for treating cancer: will it be promising?
por: Cho, Duck, et al.
Publicado: (2011)

Optical Coherence Tomography in Parkinsonian Syndromes
por: Albrecht, Philipp, et al.
Publicado: (2012)

Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
por: Tan, Shuguang, et al.
Publicado: (2016)

CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
por: Li, Tingting, et al.
Publicado: (2022)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

The Parkinsonian Syndrome : Some Points in Diagnosis and Treatment
por: Critchley, Macdonald
Publicado: (1924)

A Case of Encephalitis Lethargica with Parkinsonian Syndrome
por: De, J. C.
Publicado: (1923)

Fracture Risk Assessment in Atypical Parkinsonian Syndromes
por: Kobylecki, Christopher, et al.
Publicado: (2021)

Freezing of saccades in dopa-responsive parkinsonian syndrome
por: Likitgorn, Techawit, et al.
Publicado: (2021)

The promise of immunotherapy in genitourinary malignancies
por: Zhang, Tian, et al.
Publicado: (2018)

Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2022)

Anti-Interferon Auto-Antibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Levin, Michael
Publicado: (2006)

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Is there a role for immunotherapy in HER2-positive breast cancer?
por: Holgado, Esther, et al.
Publicado: (2018)

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease
por: Pesch, Beate, et al.
Publicado: (2019)

The Potential Effect of Statins on Rituximab Immunotherapy
por: Cragg, Mark S
Publicado: (2008)

Allergen immunotherapy: past, present and future
por: Durham, Stephen R., et al.
Publicado: (2022)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma
por: Ahn, Sungwoo, et al.
Publicado: (2021)

Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study
por: Molde, Karin, et al.
Publicado: (2017)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

Extreme immunotherapy: emergency immunology to defeat pandemics
por: Nixon, Douglas F., et al.
Publicado: (2021)

Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fep7rmvav8on0qoj5ro0qqfp5u